The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preclinical Isolated Organ Perfusion System Market Research Report 2025
Synopsis
Isolated organ perfusion involves maintaining an organ in viable status, either by single pass or recirculation with the medium. Isolated organ perfusion has been documented in distribution studies involving several organs including lung, kidney and brain. These isolated organ perfusion techniques allow higher concentrations of chemotherapy to be delivered to the targeted organ while ensuring the vitality of other organs.
The global Preclinical Isolated Organ Perfusion System market was valued at US$ 533 million in 2023 and is anticipated to reach US$ 827.3 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Preclinical Isolated Organ Perfusion System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Isolated Organ Perfusion System.
Report Scope
The Preclinical Isolated Organ Perfusion System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Isolated Organ Perfusion System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Isolated Organ Perfusion System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
World Precision Instruments
Radnoti
MDE GmbH
Harvard Bioscience
EMKA Technologies
Danish Myo Technology
ADInstruments
Experimetria
Segment by Type
Isolated Heart Perfusion Systems
Isolated Abdominal Organ Perfusion Systems
Isolated Lung Perfusion Systems
Others
Segment by Application
Industrial Laboratories and CROs
Academic and Government Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Isolated Organ Perfusion System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Isolated organ perfusion involves maintaining an organ in viable status, either by single pass or recirculation with the medium. Isolated organ perfusion has been documented in distribution studies involving several organs including lung, kidney and brain. These isolated organ perfusion techniques allow higher concentrations of chemotherapy to be delivered to the targeted organ while ensuring the vitality of other organs.
The global Preclinical Isolated Organ Perfusion System market was valued at US$ 533 million in 2023 and is anticipated to reach US$ 827.3 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Preclinical Isolated Organ Perfusion System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Isolated Organ Perfusion System.
Report Scope
The Preclinical Isolated Organ Perfusion System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Isolated Organ Perfusion System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Isolated Organ Perfusion System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
World Precision Instruments
Radnoti
MDE GmbH
Harvard Bioscience
EMKA Technologies
Danish Myo Technology
ADInstruments
Experimetria
Segment by Type
Isolated Heart Perfusion Systems
Isolated Abdominal Organ Perfusion Systems
Isolated Lung Perfusion Systems
Others
Segment by Application
Industrial Laboratories and CROs
Academic and Government Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Isolated Organ Perfusion System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Isolated Organ Perfusion System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Isolated Heart Perfusion Systems
1.2.3 Isolated Abdominal Organ Perfusion Systems
1.2.4 Isolated Lung Perfusion Systems
1.2.5 Others
1.3 Market by Application
1.3.1 Global Preclinical Isolated Organ Perfusion System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Industrial Laboratories and CROs
1.3.3 Academic and Government Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Isolated Organ Perfusion System Market Perspective (2019-2030)
2.2 Preclinical Isolated Organ Perfusion System Growth Trends by Region
2.2.1 Global Preclinical Isolated Organ Perfusion System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preclinical Isolated Organ Perfusion System Historic Market Size by Region (2019-2024)
2.2.3 Preclinical Isolated Organ Perfusion System Forecasted Market Size by Region (2025-2030)
2.3 Preclinical Isolated Organ Perfusion System Market Dynamics
2.3.1 Preclinical Isolated Organ Perfusion System Industry Trends
2.3.2 Preclinical Isolated Organ Perfusion System Market Drivers
2.3.3 Preclinical Isolated Organ Perfusion System Market Challenges
2.3.4 Preclinical Isolated Organ Perfusion System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Isolated Organ Perfusion System Players by Revenue
3.1.1 Global Top Preclinical Isolated Organ Perfusion System Players by Revenue (2019-2024)
3.1.2 Global Preclinical Isolated Organ Perfusion System Revenue Market Share by Players (2019-2024)
3.2 Global Preclinical Isolated Organ Perfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical Isolated Organ Perfusion System Revenue
3.4 Global Preclinical Isolated Organ Perfusion System Market Concentration Ratio
3.4.1 Global Preclinical Isolated Organ Perfusion System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Isolated Organ Perfusion System Revenue in 2023
3.5 Preclinical Isolated Organ Perfusion System Key Players Head office and Area Served
3.6 Key Players Preclinical Isolated Organ Perfusion System Product Solution and Service
3.7 Date of Enter into Preclinical Isolated Organ Perfusion System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Isolated Organ Perfusion System Breakdown Data by Type
4.1 Global Preclinical Isolated Organ Perfusion System Historic Market Size by Type (2019-2024)
4.2 Global Preclinical Isolated Organ Perfusion System Forecasted Market Size by Type (2025-2030)
5 Preclinical Isolated Organ Perfusion System Breakdown Data by Application
5.1 Global Preclinical Isolated Organ Perfusion System Historic Market Size by Application (2019-2024)
5.2 Global Preclinical Isolated Organ Perfusion System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preclinical Isolated Organ Perfusion System Market Size (2019-2030)
6.2 North America Preclinical Isolated Organ Perfusion System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preclinical Isolated Organ Perfusion System Market Size by Country (2019-2024)
6.4 North America Preclinical Isolated Organ Perfusion System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Isolated Organ Perfusion System Market Size (2019-2030)
7.2 Europe Preclinical Isolated Organ Perfusion System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preclinical Isolated Organ Perfusion System Market Size by Country (2019-2024)
7.4 Europe Preclinical Isolated Organ Perfusion System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size (2019-2030)
8.2 Asia-Pacific Preclinical Isolated Organ Perfusion System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size by Region (2019-2024)
8.4 Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Isolated Organ Perfusion System Market Size (2019-2030)
9.2 Latin America Preclinical Isolated Organ Perfusion System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preclinical Isolated Organ Perfusion System Market Size by Country (2019-2024)
9.4 Latin America Preclinical Isolated Organ Perfusion System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size (2019-2030)
10.2 Middle East & Africa Preclinical Isolated Organ Perfusion System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size by Country (2019-2024)
10.4 Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 World Precision Instruments
11.1.1 World Precision Instruments Company Detail
11.1.2 World Precision Instruments Business Overview
11.1.3 World Precision Instruments Preclinical Isolated Organ Perfusion System Introduction
11.1.4 World Precision Instruments Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024)
11.1.5 World Precision Instruments Recent Development
11.2 Radnoti
11.2.1 Radnoti Company Detail
11.2.2 Radnoti Business Overview
11.2.3 Radnoti Preclinical Isolated Organ Perfusion System Introduction
11.2.4 Radnoti Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024)
11.2.5 Radnoti Recent Development
11.3 MDE GmbH
11.3.1 MDE GmbH Company Detail
11.3.2 MDE GmbH Business Overview
11.3.3 MDE GmbH Preclinical Isolated Organ Perfusion System Introduction
11.3.4 MDE GmbH Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024)
11.3.5 MDE GmbH Recent Development
11.4 Harvard Bioscience
11.4.1 Harvard Bioscience Company Detail
11.4.2 Harvard Bioscience Business Overview
11.4.3 Harvard Bioscience Preclinical Isolated Organ Perfusion System Introduction
11.4.4 Harvard Bioscience Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024)
11.4.5 Harvard Bioscience Recent Development
11.5 EMKA Technologies
11.5.1 EMKA Technologies Company Detail
11.5.2 EMKA Technologies Business Overview
11.5.3 EMKA Technologies Preclinical Isolated Organ Perfusion System Introduction
11.5.4 EMKA Technologies Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024)
11.5.5 EMKA Technologies Recent Development
11.6 Danish Myo Technology
11.6.1 Danish Myo Technology Company Detail
11.6.2 Danish Myo Technology Business Overview
11.6.3 Danish Myo Technology Preclinical Isolated Organ Perfusion System Introduction
11.6.4 Danish Myo Technology Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024)
11.6.5 Danish Myo Technology Recent Development
11.7 ADInstruments
11.7.1 ADInstruments Company Detail
11.7.2 ADInstruments Business Overview
11.7.3 ADInstruments Preclinical Isolated Organ Perfusion System Introduction
11.7.4 ADInstruments Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024)
11.7.5 ADInstruments Recent Development
11.8 Experimetria
11.8.1 Experimetria Company Detail
11.8.2 Experimetria Business Overview
11.8.3 Experimetria Preclinical Isolated Organ Perfusion System Introduction
11.8.4 Experimetria Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024)
11.8.5 Experimetria Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Preclinical Isolated Organ Perfusion System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Isolated Heart Perfusion Systems
Table 3. Key Players of Isolated Abdominal Organ Perfusion Systems
Table 4. Key Players of Isolated Lung Perfusion Systems
Table 5. Key Players of Others
Table 6. Global Preclinical Isolated Organ Perfusion System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Preclinical Isolated Organ Perfusion System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Preclinical Isolated Organ Perfusion System Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Preclinical Isolated Organ Perfusion System Market Share by Region (2019-2024)
Table 10. Global Preclinical Isolated Organ Perfusion System Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Preclinical Isolated Organ Perfusion System Market Share by Region (2025-2030)
Table 12. Preclinical Isolated Organ Perfusion System Market Trends
Table 13. Preclinical Isolated Organ Perfusion System Market Drivers
Table 14. Preclinical Isolated Organ Perfusion System Market Challenges
Table 15. Preclinical Isolated Organ Perfusion System Market Restraints
Table 16. Global Preclinical Isolated Organ Perfusion System Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Preclinical Isolated Organ Perfusion System Market Share by Players (2019-2024)
Table 18. Global Top Preclinical Isolated Organ Perfusion System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Isolated Organ Perfusion System as of 2023)
Table 19. Ranking of Global Top Preclinical Isolated Organ Perfusion System Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Preclinical Isolated Organ Perfusion System Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Preclinical Isolated Organ Perfusion System Product Solution and Service
Table 23. Date of Enter into Preclinical Isolated Organ Perfusion System Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Preclinical Isolated Organ Perfusion System Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Preclinical Isolated Organ Perfusion System Revenue Market Share by Type (2019-2024)
Table 27. Global Preclinical Isolated Organ Perfusion System Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Preclinical Isolated Organ Perfusion System Revenue Market Share by Type (2025-2030)
Table 29. Global Preclinical Isolated Organ Perfusion System Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Preclinical Isolated Organ Perfusion System Revenue Market Share by Application (2019-2024)
Table 31. Global Preclinical Isolated Organ Perfusion System Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Preclinical Isolated Organ Perfusion System Revenue Market Share by Application (2025-2030)
Table 33. North America Preclinical Isolated Organ Perfusion System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Preclinical Isolated Organ Perfusion System Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Preclinical Isolated Organ Perfusion System Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Preclinical Isolated Organ Perfusion System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Preclinical Isolated Organ Perfusion System Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Preclinical Isolated Organ Perfusion System Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Preclinical Isolated Organ Perfusion System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Preclinical Isolated Organ Perfusion System Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Preclinical Isolated Organ Perfusion System Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size by Country (2025-2030) & (US$ Million)
Table 48. World Precision Instruments Company Detail
Table 49. World Precision Instruments Business Overview
Table 50. World Precision Instruments Preclinical Isolated Organ Perfusion System Product
Table 51. World Precision Instruments Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024) & (US$ Million)
Table 52. World Precision Instruments Recent Development
Table 53. Radnoti Company Detail
Table 54. Radnoti Business Overview
Table 55. Radnoti Preclinical Isolated Organ Perfusion System Product
Table 56. Radnoti Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024) & (US$ Million)
Table 57. Radnoti Recent Development
Table 58. MDE GmbH Company Detail
Table 59. MDE GmbH Business Overview
Table 60. MDE GmbH Preclinical Isolated Organ Perfusion System Product
Table 61. MDE GmbH Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024) & (US$ Million)
Table 62. MDE GmbH Recent Development
Table 63. Harvard Bioscience Company Detail
Table 64. Harvard Bioscience Business Overview
Table 65. Harvard Bioscience Preclinical Isolated Organ Perfusion System Product
Table 66. Harvard Bioscience Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024) & (US$ Million)
Table 67. Harvard Bioscience Recent Development
Table 68. EMKA Technologies Company Detail
Table 69. EMKA Technologies Business Overview
Table 70. EMKA Technologies Preclinical Isolated Organ Perfusion System Product
Table 71. EMKA Technologies Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024) & (US$ Million)
Table 72. EMKA Technologies Recent Development
Table 73. Danish Myo Technology Company Detail
Table 74. Danish Myo Technology Business Overview
Table 75. Danish Myo Technology Preclinical Isolated Organ Perfusion System Product
Table 76. Danish Myo Technology Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024) & (US$ Million)
Table 77. Danish Myo Technology Recent Development
Table 78. ADInstruments Company Detail
Table 79. ADInstruments Business Overview
Table 80. ADInstruments Preclinical Isolated Organ Perfusion System Product
Table 81. ADInstruments Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024) & (US$ Million)
Table 82. ADInstruments Recent Development
Table 83. Experimetria Company Detail
Table 84. Experimetria Business Overview
Table 85. Experimetria Preclinical Isolated Organ Perfusion System Product
Table 86. Experimetria Revenue in Preclinical Isolated Organ Perfusion System Business (2019-2024) & (US$ Million)
Table 87. Experimetria Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical Isolated Organ Perfusion System Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Preclinical Isolated Organ Perfusion System Market Share by Type: 2023 VS 2030
Figure 3. Isolated Heart Perfusion Systems Features
Figure 4. Isolated Abdominal Organ Perfusion Systems Features
Figure 5. Isolated Lung Perfusion Systems Features
Figure 6. Others Features
Figure 7. Global Preclinical Isolated Organ Perfusion System Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Preclinical Isolated Organ Perfusion System Market Share by Application: 2023 VS 2030
Figure 9. Industrial Laboratories and CROs Case Studies
Figure 10. Academic and Government Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Preclinical Isolated Organ Perfusion System Report Years Considered
Figure 13. Global Preclinical Isolated Organ Perfusion System Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Preclinical Isolated Organ Perfusion System Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Preclinical Isolated Organ Perfusion System Market Share by Region: 2023 VS 2030
Figure 16. Global Preclinical Isolated Organ Perfusion System Market Share by Players in 2023
Figure 17. Global Top Preclinical Isolated Organ Perfusion System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Isolated Organ Perfusion System as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Preclinical Isolated Organ Perfusion System Revenue in 2023
Figure 19. North America Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Preclinical Isolated Organ Perfusion System Market Share by Country (2019-2030)
Figure 21. United States Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Preclinical Isolated Organ Perfusion System Market Share by Country (2019-2030)
Figure 25. Germany Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Preclinical Isolated Organ Perfusion System Market Share by Region (2019-2030)
Figure 33. China Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Preclinical Isolated Organ Perfusion System Market Share by Country (2019-2030)
Figure 41. Mexico Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Preclinical Isolated Organ Perfusion System Market Share by Country (2019-2030)
Figure 45. Turkey Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Preclinical Isolated Organ Perfusion System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. World Precision Instruments Revenue Growth Rate in Preclinical Isolated Organ Perfusion System Business (2019-2024)
Figure 48. Radnoti Revenue Growth Rate in Preclinical Isolated Organ Perfusion System Business (2019-2024)
Figure 49. MDE GmbH Revenue Growth Rate in Preclinical Isolated Organ Perfusion System Business (2019-2024)
Figure 50. Harvard Bioscience Revenue Growth Rate in Preclinical Isolated Organ Perfusion System Business (2019-2024)
Figure 51. EMKA Technologies Revenue Growth Rate in Preclinical Isolated Organ Perfusion System Business (2019-2024)
Figure 52. Danish Myo Technology Revenue Growth Rate in Preclinical Isolated Organ Perfusion System Business (2019-2024)
Figure 53. ADInstruments Revenue Growth Rate in Preclinical Isolated Organ Perfusion System Business (2019-2024)
Figure 54. Experimetria Revenue Growth Rate in Preclinical Isolated Organ Perfusion System Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
